Zantac 75 tablets

Negara: Inggris

Bahasa: Inggris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Ranitidine hydrochloride

Tersedia dari:

Omega Pharma Ltd

Kode ATC:

A02BA02

INN (Nama Internasional):

Ranitidine hydrochloride

Dosis:

75mg

Bentuk farmasi:

Oral tablet

Rute administrasi :

Oral

Kelas:

No Controlled Drug Status

Jenis Resep:

Valid as a prescribable product

Ringkasan produk:

BNF: 01030100; GTIN: 5000123109647 5000347087042

Selebaran informasi

Read all of this leaflet carefully before you start taking
this medicine because it contains important information
for you.
Always take this medicine exactly as described in this
leaflet or as your doctor or pharmacist have told you.
•
Keep this leaflet. You may need to read it again.
•
Ask your pharmacist if you need more information or
advice.
•
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
•
You must talk to a doctor if you do not feel better or
if you feel worse after 2 weeks.
IN THIS LEAFLET:
1. What Zantac 75 is and what it is used for
2. What you need to know before you take Zantac 75
3. How to take Zantac 75
4. Possible side effects
5. How to store Zantac 75
6. Contents of the pack and other information
1. What Zantac 75 is and what it is
used for
ZANTAC 75 IS USED TO TREAT AND PREVENT INDIGESTION AND
HEARTBURN FOR UP TO 12 HOURS.
THE STOMACH PRODUCES ACID WHICH HELPS TO DIGEST FOOD.
SOMETIMES YOUR STOMACH PRODUCES TOO MUCH ACID WHICH
CAN CAUSE INDIGESTION AND HEARTBURN.
THE ACTIVE INGREDIENT IS RANITIDINE HYDROCHLORIDE WHICH IS
A MEDICINE CALLED AN 'H2-BLOCKER’. IT WORKS BY PREVENTING
YOUR STOMACH FROM PRODUCING TOO MUCH ACID.
You must talk to a doctor if you do not feel better or if
you feel worse after 2 weeks.
2. What you need to know before
you take Zantac 75
DO NOT TAKE ZANTAC 75:
•
if you are ALLERGIC TO RANITIDINE OR ANY OF THE
OTHER INGREDIENTS OF THIS MEDICINE (listed in
section 6).
•
if you are UNDER 16 YEARS.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Zantac
75.
•
if you have KIDNEY or LIVER PROBLEMS
•
if you have PORPHYRIA (too much of the pigment
called porphyrin which may discolour the urine)
•
if you have UNINTENDED WEIGHT LOSS ASSOCIATED WITH
ACID INDIGESTION
•
if you are MIDDLE-AGED or older with NEW or RECENTLY
CHANGED INDIGESTION symptoms
•
if you have PERSISTENT STOMACH PAIN
•
if you are under REGULAR MEDICAL SUPERVISION
•
if yo

Karakteristik produk

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Zantac 75
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains ranitidine hydrochloride 84mg (equivalent to
ranitidine 75mg)
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-coated tablet (tablet).
Pink, five-sided, biconvex, film-coated tablet.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Symptomatic
relief
of
heartburn,
indigestion,
acid
indigestion
and
hyperacidity.
For prevention of acid indigestion, indigestion, hyperacidity and
heartburn
associated with consuming food and drink.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Route of Administration:
Oral
Posology
_ _
_Adults (including the elderly) and children 16 years of age and
older: _
Swallow one Zantac 75 tablet whole, with a drink of water, as soon as
you have
symptoms. If symptoms persist for more than one hour or return, take
another tablet.
Do not take more than four tablets in 24 hours.
For prevention of acid indigestion, indigestion, hyperacidity and
heartburn associated
with consuming food and drink, swallow one tablet with water, half to
one hour
beforehand.
Patients will be advised not to take the tablets for more than 2 weeks
continuously and
to consult their doctor if symptoms get worse or persist after 2 weeks
treatment.
_Children under 16 years _
Not recommended for children under 16 years of age.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance(s) or to any of the
excipients listed in
section 6.1
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Treatment with a histamine H
2
-antagonist may mask symptoms associated
with carcinoma of the stomach and may therefore delay diagnosis of the
condition.
Ranitidine is excreted via the kidney and so plasma levels of the drug
are
increased in patients with renal impairment (creatinine clearance less
than 50
ml/min). Zantac 75 is not suitable for these patients without medical
supervision.
Patients who are taking non-steroidal anti-inflammatory drugs
especially in
those with a history